(SMST) Defiance Daily Target 1.5x - Ratings and Ratios
Inverse, Leveraged, Short
Description: SMST Defiance Daily Target 1.5x
The Defiance Daily Target 1.5x Short MSTR ETF (NASDAQ:SMST) is designed to provide investors with a magnified inverse exposure to the daily performance of MicroStrategy Incorporated (MSTR). The fund achieves this through a strategic allocation of at least 80% of its investment exposure to financial instruments that should yield 2 times the inverse daily return of MSTR, although it targets 1.5x short exposure, indicating a potential adjustment in the investment strategy or a specific rebalancing mechanism.
As a non-diversified ETF, SMST focuses its investments on a specific area, in this case, the inverse performance of MSTR, making it a specialized tool for investors looking to hedge against or speculate on the daily movements of MSTR. The funds structure is particularly suited for short-term trading strategies rather than long-term investments due to its daily rebalancing and the compounding effects of daily returns.
Analyzing the available
Considering the
Forecasting SMSTs performance involves analyzing both the technical and fundamental aspects. Given the current downtrend indicated by the SMAs and the high volatility, its plausible that SMST could continue to experience significant price swings. If MSTRs stock price continues to rise, SMST is likely to decline further due to its inverse exposure. Conversely, if MSTRs stock price drops, SMST could see a significant increase. However, the 1.5x short target might be challenging to maintain with the available financial instruments providing 2 times the inverse exposure, potentially leading to tracking errors. Investors should closely monitor MSTRs daily performance and adjust their strategies accordingly.
To make an informed investment decision, its crucial to analyze MSTRs daily performance and overall market conditions. If youre considering investing in SMST, be prepared for the potential of significant losses if MSTRs stock price moves contrary to the funds inverse strategy. The high volatility and the specific focus on MSTR make SMST more suitable for experienced traders who can closely monitor and adjust their positions daily.
Additional Sources for SMST ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
SMST ETF Overview
Market Cap in USD | 32m |
Category | Trading--Inverse Equity |
IPO / Inception | 2024-08-20 |
SMST ETF Ratings
Growth Rating | -49.0 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -98.9 |
Analysts | - |
Fair Price Momentum | 22.71 USD |
Fair Price DCF | - |
SMST Dividends
Currently no dividends paidSMST Growth Ratios
Growth Correlation 3m | -68% |
Growth Correlation 12m | -94.9% |
Growth Correlation 5y | -94.9% |
CAGR 5y | -98.70% |
CAGR/Max DD 5y | -1.00 |
Sharpe Ratio 12m | -0.16 |
Alpha | -95.89 |
Beta | -0.787 |
Volatility | 175.61% |
Current Volume | 538.8k |
Average Volume 20d | 1071.2k |
Stop Loss | 21.9 (-8.1%) |
As of July 09, 2025, the stock is trading at USD 23.83 with a total of 538,828 shares traded.
Over the past week, the price has changed by -12.90%, over one month by -8.52%, over three months by -77.98% and over the past year by -98.70%.
Probably not. Based on ValueRay´s Analyses, Defiance Daily Target 1.5x (NASDAQ:SMST) is currently (July 2025) not a good stock to buy. It has a ValueRay Growth Rating of -48.98 and therefor a somwhat technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SMST is around 22.71 USD . This means that SMST is currently overvalued and has a potential downside of -4.7%.
Defiance Daily Target 1.5x has no consensus analysts rating.
According to our own proprietary Forecast Model, SMST Defiance Daily Target 1.5x will be worth about 24.5 in July 2026. The stock is currently trading at 23.83. This means that the stock has a potential upside of +2.94%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 24.5 | 2.9% |